Zydus Lifesciences
ZYDUSLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Pankaj R Patel · MD: Sharvil P Patel · Listing date: April 28, 2000 · Employees: 24412 · Ahmedabad · http://www.zyduscadila.com

Stock Price vs Company Growth
1d
7.0%
1w
2.7%
1m
8.0%
3m
16.9%
6m
19.4%
1y
12.8%
5y
19.7%
10y
9.9%
all
17.9%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

822 7.0%
797
1,026
Company Overview

Sales
22,247 Cr
Growth: 15.5%
Profit after Tax
4,537 Cr
Growth: 5.4%
Large Cap
82,722 Cr
P/E: 18.3x
Industry P/E: 30.4x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 22,247
Growth 15.5%
EBITDA 29.3%
P/S 3.7x
Dividend 0.2%
P/E 18.3x
Book Value ₹ 230
PEG Ratio 1.2x
ROE 21.0%
P/B 3.6x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
3.63 %
Kotak Flexicap Fund
2.28 %
Government Pension Fund Global
1.15 %
Iepf
0.12 %
Llp
0.07 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21
Promoters
Zydus Family Trust
74.86 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21
Others
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Sep21
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.
Investors (134)
Followers (34)